Bicocca Open Archive

Logo unimib boa
FUMAGALLI, GIULIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.269
AS - Asia 4.748
EU - Europa 3.357
SA - Sud America 635
AF - Africa 111
OC - Oceania 28
Continente sconosciuto - Info sul continente non disponibili 7
Totale 17.155
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.770
SG - Singapore 1.679
CN - Cina 1.021
VN - Vietnam 673
IT - Italia 652
HK - Hong Kong 610
RU - Federazione Russa 558
DE - Germania 509
BR - Brasile 471
SE - Svezia 451
CA - Canada 440
GB - Regno Unito 281
IE - Irlanda 270
FR - Francia 165
IN - India 158
BD - Bangladesh 110
KR - Corea 89
UA - Ucraina 83
ID - Indonesia 75
FI - Finlandia 68
TR - Turchia 68
DK - Danimarca 67
AR - Argentina 64
JP - Giappone 49
NL - Olanda 40
AT - Austria 38
ZA - Sudafrica 38
LT - Lituania 35
MX - Messico 34
IQ - Iraq 33
ES - Italia 27
PL - Polonia 27
BE - Belgio 24
CO - Colombia 24
SA - Arabia Saudita 24
AU - Australia 23
PK - Pakistan 23
EC - Ecuador 22
EG - Egitto 19
PH - Filippine 19
CH - Svizzera 16
VE - Venezuela 15
PY - Paraguay 14
ET - Etiopia 13
KZ - Kazakistan 12
IR - Iran 11
UZ - Uzbekistan 11
MY - Malesia 10
TN - Tunisia 10
JO - Giordania 9
TW - Taiwan 9
RO - Romania 8
UY - Uruguay 8
CL - Cile 7
HR - Croazia 7
MA - Marocco 7
NP - Nepal 7
AZ - Azerbaigian 6
CZ - Repubblica Ceca 6
IL - Israele 6
TH - Thailandia 6
BG - Bulgaria 5
BO - Bolivia 5
CR - Costa Rica 5
EU - Europa 5
OM - Oman 5
PA - Panama 5
PT - Portogallo 5
RS - Serbia 5
AE - Emirati Arabi Uniti 4
AO - Angola 4
DZ - Algeria 4
KG - Kirghizistan 4
NZ - Nuova Zelanda 4
GR - Grecia 3
GT - Guatemala 3
HN - Honduras 3
KE - Kenya 3
LY - Libia 3
PE - Perù 3
BH - Bahrain 2
CY - Cipro 2
DO - Repubblica Dominicana 2
GY - Guiana 2
JM - Giamaica 2
LB - Libano 2
MM - Myanmar 2
MU - Mauritius 2
NO - Norvegia 2
PS - Palestinian Territory 2
SC - Seychelles 2
SK - Slovacchia (Repubblica Slovacca) 2
TT - Trinidad e Tobago 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
CG - Congo 1
CW - ???statistics.table.value.countryCode.CW??? 1
HU - Ungheria 1
KH - Cambogia 1
KW - Kuwait 1
Totale 17.140
Salva come PNG Salva come JPEG
Città #
Ann Arbor 1.897
Singapore 1.033
Dallas 606
Hong Kong 588
Ashburn 580
San Jose 473
Toronto 356
Wilmington 347
Chandler 323
Frankfurt am Main 289
Dublin 262
Milan 240
Dearborn 236
New York 195
Los Angeles 186
Woodbridge 185
Ho Chi Minh City 174
Houston 157
Santa Clara 152
Hanoi 144
Fairfield 139
Beijing 136
Princeton 134
Nanjing 113
Chicago 112
Boardman 104
Jacksonville 88
The Dalles 77
Council Bluffs 74
Seattle 71
Guangzhou 67
Moscow 65
Lauterbourg 63
Seoul 62
Jakarta 53
Shanghai 50
Buffalo 48
Basingstoke 46
Nanchang 42
Orem 42
Dong Ket 41
São Paulo 40
Cambridge 38
Helsinki 37
Lawrence 32
Munich 31
Vienna 31
Columbus 29
Shenyang 29
Vilnius 28
Da Nang 27
Altamura 26
Hangzhou 25
Chennai 24
Hefei 24
Zhengzhou 24
Atlanta 23
Denver 22
Montreal 22
Phoenix 22
Pune 22
Shangdi 21
Tokyo 21
Haiphong 20
Jinan 20
Brussels 19
London 19
Ottawa 19
Warsaw 19
Rio de Janeiro 18
Brooklyn 17
Kunming 17
Manchester 17
Sacramento 17
Sydney 17
Baghdad 16
Changsha 16
Tianjin 16
Andover 15
Fremont 15
Portland 15
Rome 15
Falls Church 14
Johannesburg 14
Kent 14
Kocaeli 14
Mainz 14
Poplar 14
Addis Ababa 13
Belo Horizonte 13
Redondo Beach 13
San Francisco 13
Stockholm 13
Dhaka 12
Edmonton 12
Ha Long 12
Hải Dương 12
Mexico City 12
Nuremberg 12
San Diego 12
Totale 11.208
Salva come PNG Salva come JPEG
Nome #
Human Intravenous Immunoglobulin Alleviates Neuropathic Symptoms in a Rat Model of Paclitaxel-Induced Peripheral Neurotoxicity 458
Protective Effect of Human Mesenchymal Stem Cells on the Survival of Pancreatic Islets 452
The role of Neurofilament Light Chain as a serum biomarker in chemotherapy-induced peripheral neurotoxicity rat models 450
High-dose intravenous immunoglobulins reduce nerve macrophage infiltration and the severity of bortezomib-induced peripheral neurotoxicity in rats 428
Role of Organic Transporters 1 and 2 in Cisplatin mediated neurotoxicity 413
Topiramate prevents oxaliplatin-related axonal hyperexcitability and oxaliplatin induced peripheral neurotoxicity 401
The relevance of multimodal assessment in experimental oxaliplatin-induced peripheral neurotoxicity 388
Neurofilament light chain: a specific serum biomarker of axonal damage severity in rat models of Chemotherapy-Induced Peripheral Neurotoxicity 384
Calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity 375
Pathogenic role of delta 2 tubulin in bortezomib-induced peripheral neuropathy 371
Neuroinflammatory Process Involved in Different Preclinical Models of Chemotherapy-Induced Peripheral Neuropathy 343
Molsidomine provides neuroprotection against vincristine-induced peripheral neurotoxicity through soluble guanylyl cyclase activation 333
Molsidomine reduces the severity of Vincristine-induced peripheral neurotoxicity in rats 325
Systems Pharmacology Modeling Identifies a Novel Treatment Strategy for Bortezomib-Induced Neuropathic Pain 321
The validation of neuroactive drug selection based on combinatorial screening in bortezomib-induced neurotoxicity models. 320
Neuronopathies and polyneuropathies: a ready to use translational neurophysiological protocol in rodent models 316
Assessment of oxaliplatin-induced peripheral neurotoxicity with different treatment schedules 306
Neurofilament light chain as disease biomarker in a rodent model of chemotherapy induced peripheral neuropathy 304
An in vivo and in vitro neurophysiological approach to acute and chronic oxaliplatin-induced peripheral neurotoxicity 301
Sensory-motor paclitaxel polyneuropathy characterization in a rat model 297
Nerve Excitability Testing to Unravel Chemotherapy Induced Peripheral Neurotoxicity (CIPN) Pathogenesis: Altered Axonal Excitability as a Possible Pivotal Event Related to Platinum Compounds and Taxanes 293
Macrophage infiltration in different preclinical models of chemotherapy-induced peripheral neurotoxicity 292
Molsidomide provides neuroprotection against vincristine-induced peripheral neurotoxicity 279
Addressing the Need of a Translational Approach in Peripheral Neuropathy Research: Morphology Meets Function 278
Reply to a comment paper on the published paper by canta, a. Et al: “calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity”—antioxidants 2020, 9, 594 275
Animal Models for the Study of Human Central and Peripheral Nervous System Diseases 272
Oxaliplatin induced peripheral neurotoxicity (OIPN) and ion unbalance: the perilous link between acute and chronic neurotoxicity. 270
Multimodal experimental approach to the study of human neurological diseases 268
Study of perpheral neurotoxicity of different doses of oxaliplatin in cd1 mice 261
Morphology meets function to unravel Oxaliplatin Induced Peripheral Neurotoxicity (OIPN) 253
ENDOCANNABINOID SYSTEM IN BORTEZOMIB NEUROTOXICITY 247
Genetic factors influencing the development of vincristine-induced neurotoxicity 247
7T MRI first exploitation in a chemotherapy induced peripheral neurotoxicity in vivo model. 241
EVALUATION OF THE EFFICACY OF PERIPHAGEN NEUROTROPHIN-3 EXPRESSING VECTOR FOR OXALIPLATIN INDUCED PERIPHERAL NEUROPATHY. 233
ACCURATE NEUROPHYSIOLOGICAL MONITORING FOR SENSORY NEUROPATHY IN MOUSE MODELS OF CHEMOTHERAPY INDUCED PERIPHERAL NEUROTOXICITY 232
DIFFERENT DEGREES OF MACROPHAGE INFILTRATION IN PRECLINICAL MODELS OF ANTITUBULIN AGENTS-INDUCED PERIPHERAL NEUROTOXICITY 230
A Possible role of OCT2 gene in the development of peripheral neurotoxicity induced by cisplatin 224
Intravenous Immunoglobulin Preparation Attenuates Pain Behaviors in a Wistar Rat Model of Bortezomib-Induced Peripheral Neuropathy 224
Ivig Effect In A Wistar Rat Model Of Bortezomib-Induced Peripheral Neuropathy 223
Topiramate Prevents Oxaliplatin Neurotoxicity in a rat model 220
Tackling Oxaliplatin Induced Peripheral neurotoxicity: from bed to bench side and back. 216
Effect of preventive and therapeutic treatment of ghrelin agonist HM01 on the peripheral neurotoxicity induced by bortezomib in wistar rats. 214
Blood neurofilament light chains as a potential damage marker in chemotherapy-induce peripheral neuropathy rodent models 214
How to assess models of oxaliplatin induced peripheral neurotoxicity – a neurophysiological translational approach 213
NERVE EXCITABILITY TESTING AS THE LINK BETWEEN ANATOMY AND PHYSIOLOGY: AXONAL EXCITABILITY TESTING TO TEST IN VIVO MECHANISMS OF PERIPHERAL NERVE DAMAGE. 210
Oxaliplatin induced peripheral neurotoxicity (OIPN): a translational approach for drug discovery. 209
Advanced neurophysiology - a translational approach to neuropathy and neuropathic pain 206
Long-term recovery from chemotherapy-induced neuropathy following paclitaxel, ixabepilone, eribulin and vinorelbine in mice 205
Making connections: gap junctions are pivotal for MSC-induced long lasting survival of sensory neurons 205
The severity of oxaliplatin neurotoxicity is related to differential expression of a solute transporter in mice 202
Erratum: Pathogenic role of delta 2 tubulin in bortezomib-induced peripheral neuropathy (Proceedings of the National Academy of Sciences of the United States of America (2021) 118 (e2012685118) DOI: 10.1073/pnas.2012685118) 202
Early stimulation of trek channel transcription and activity induced by oxaliplatin-dependent cytosolic acidification 201
Translating morphology from bench side to bed side via neurophysiology: 8-minute protocol for peripheral neuropathy research 201
Pharmacokinetics of IVIg in Wistar rats 198
In vitro neurotoxicity of new promising metal-based anticancer complexes 196
Ghrelin agonist HM01 attenuates chemotherapy-induced neurotoxicity in rodent models 196
EMG Recordings at Rest to Verify Axonal Hyperexcitability in a Rat Model of Oxaliplatin Induced Peripheral Neurotoxicity 196
Oxaliplatin induced peripheral neurotoxicity – a neurophysiological translational approach 188
An innovative traslational approach to oxaliplatin induced peripheral neurotoxicity in animal models: nerve excitability testing. 187
STANDARD AND ADVANCED NEUROPHYSIOLOGY SET UP IN MOUSE MODELS: SENSORY RECORDINGS AND NERVE EXCITABILITY TESTING OF THE CAUDAL NERVE. 182
Assessment of Neurofilament Light Protein as a Serum Biomarker in Rodent Models of Toxic-Induced Peripheral Neuropathy 179
Topiramate neuroprotectant effects against oxaliplatin induced peripheral neurotoxicity 171
Translational approach to chemotherapy induced peripheral neurotoxicity (cipn) – neurophysiology as the link between bench and bed-side 168
Neurofilament light protein: a blood biomarker of neurodegeneration in chemotherapy-induced peripheral neurotoxicity. 166
Oxaliplatin induced Peripheral Neurotoxicity (OIPN): a Rat Model that full encompasses all OIPN Phenomena 165
Nerve Excitability Testing: An In Vivo Translational Approach To Investigate Oxaliplatin Induced Peripheral Neurotoxicity Pathogenesis And Treatment 159
Oxaliplatin induced peripheral neurotoxicity: nerve excitability testing full profile in a long term toxicity animal study 156
Blood NfL as a potential axonal damage marker in different CIPN rat models. 134
The Link between Bench and Bed-Side: “clinical” neurophysiological approach to a rat model of neuropathy 132
TOPIRAMATE PREVENTS OXALIPLATIN ACUTE PERIPHERAL NEUROTOXICITY. 125
Totale 17.944
Salva come PNG Salva come JPEG
Categoria #
all - tutte 54.945
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 54.945
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021241 0 0 0 0 0 0 0 0 0 0 0 241
2021/20221.131 126 166 145 119 88 91 50 45 38 51 72 140
2022/20231.389 163 316 174 120 98 243 21 65 92 26 55 16
2023/20241.002 27 38 30 36 122 235 160 84 61 20 13 176
2024/20252.773 139 363 248 115 236 92 189 97 286 396 222 390
2025/20266.865 754 464 855 581 633 388 1.070 314 530 556 516 204
Totale 17.944